FDA approves Eli Lilly’s weight loss drug to treat sleep apnea Zepbound was approved to treat adults with moderate to severe obstructive sleep apnea.

Sleep apnea can have long-term effects on your health, which is why a diagnosis and treatment is so important.

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first ...

Zepbound was approved last year to treat obesity. The drug's maker, Eli Lilly, says it reduces the severity of obstructive sleep apnea by 63%.

Obstructive sleep apnea can be the cause, particularly in menopausal women — but CPAP machines, considered the gold standard for treatment, don’t always work.

FILE - A woman demonstrates how she puts on her sleep apnea breathing device at her home in Los Angeles Thursday, July 12, 2018. Tirzepatide, used to treat diabetes and obesity, can help with ...

New research shows obstructive sleep apnea severity increases 18% on weekends compared to weekdays. A sleep expert discusses ...

Zepbound was approved last year to treat obesity. The drug's maker, Eli Lilly, says it reduces the severity of obstructive sleep apnea by 63%.